ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
3,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
10,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
12,2,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
13,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
13,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
14,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
15,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
15,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
16,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
16,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
16,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
16,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
18,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
19,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
19,2,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
19,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
19,4,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
20,1,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
21,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
